Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of a Skin-Directed Scoring System for Stevens-Johnson Syndrome and Epidermal Necrolysis: A Delphi Consensus Exercise.
Waters M, Dobry A, Le ST, Shinkai K, Beachkofsky TM, Davis MDP, Dominguez AR, Kroshinsky D, Markova A, Micheletti RG, Mostaghimi A, Pasieka HB, Rosenbach M, Seminario-Vidal L, Trinidad J, Albrecht J, Altman EM, Arakaki R, Ardern-Jones M, Bridges AG, Cardones AR, Chadha AA, Chen JK, Chen ST, Cheng K, Daveluy S, DeNiro KL, Harp J, Keller JJ, King B, Korman AM, Lowenstein EJ, Luxenberg E, Mancuso JB, Mauskar MM, Milam P, Motaparthi K, Nelson CA, Nguyen CV, Nutan F, Ortega-Loayza AG, Patel T, Rahnama-Moghadam S, Rekhtman S, Rojek NW, Sarihan M, Shaigany S, Sharma TR, Shearer SM, Shields BE, Strowd LC, Tartar DM, Thomas C, Wanat KA, Walls AC, Zaba LC, Ziemer CM, Maverakis E, Kaffenberger BH. Waters M, et al. Among authors: ardern jones m. JAMA Dermatol. 2023 Jul 1;159(7):772-777. doi: 10.1001/jamadermatol.2023.1347. JAMA Dermatol. 2023. PMID: 37256599
Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms: A Delphi-Based International Consensus.
Brüggen MC, Walsh S, Ameri MM, Anasiewicz N, Maverakis E, French LE, Ingen-Housz-Oro S; DRESS Delphi consensus group; Abe R, Ardern-Jones M, Assier H, Barbaud A, Bensaid B, Bernal W, Bernier C, Brassard A, Brezinová E, Cabañas R, Cardones A, Chu CY, Chua SL, Descamps V, Didona B, Divito SJ, Dodiuk-Gad R, Elman S, Gaspar K, Mortz CG, Hama N, Lee HY, Horváth B, Jörg L, Kaffenberger BH, Kucinskiene V, Lebrun-Vignes B, Lehloenya RJ, Meyersburg D, Micheletti R, Milpied B, Miyagawa F, Mostaghimi A, Nägeli M, Naldi L, Oppel E, Phillips EJ, Pirani T, Ranki A, Mälkönen T, Rosenbach M, Salavastru C, Staumont-Salle D, Sandberg H, Setterfield J, Shinkai K, Shiohara T, Soria A, Tartar D, Tiplica GS, Traidl S, Vorobyev A, von Wachter C, Worswick S, Cho YT. Brüggen MC, et al. Among authors: ardern jones m. JAMA Dermatol. 2024 Jan 1;160(1):37-44. doi: 10.1001/jamadermatol.2023.4450. JAMA Dermatol. 2024. PMID: 37966824
Shared Genetic Risk Variants in Both Male and Female Frontal Fibrosing Alopecia.
Rayinda T, McSweeney SM, Fenton D, Stefanato CM, Harries M, Palamaras I, Tidman A, Holmes S, Koutalopoulou A, Ardern-Jones M, Williams G, Papanikou S, Chasapi V, Vañó-Galvan S, Saceda-Corralo D, Melián-Olivera A, Azcarraga-Llobet C, Lobato-Berezo A, Bustamante M, Sunyer J, Starace MVR, Piraccini BM, Wiss IP, Senna MM, Singh R, Hilmann K, Kanti-Schmidt V, Blume-Peytavi U, Simpson M, McGrath JA, Dand N, Tziotzios C. Rayinda T, et al. Among authors: ardern jones m. J Invest Dermatol. 2023 Nov;143(11):2311-2314.e5. doi: 10.1016/j.jid.2023.04.022. Epub 2023 May 19. J Invest Dermatol. 2023. PMID: 37211199 Free article. No abstract available.
Glycolysis: An early marker for vancomycin-specific T-cell activation.
Gardner J, Hammond S, Jensen R, Gibson A, Krantz MS, Ardern-Jones M, Phillips EJ, Pirmohamed M, Chadwick AE, Betts C, Naisbitt DJ. Gardner J, et al. Among authors: ardern jones m. Clin Exp Allergy. 2024 Jan;54(1):21-33. doi: 10.1111/cea.14423. Epub 2024 Jan 4. Clin Exp Allergy. 2024. PMID: 38177093 Free PMC article.
Impaired expression of metallothioneins contributes to allergen-induced inflammation in patients with atopic dermatitis.
Sirvent S, Vallejo AF, Corden E, Teo Y, Davies J, Clayton K, Seaby EG, Lai C, Ennis S, Alyami R, Douilhet G, Dean LSN, Loxham M, Horswill S, Healy E, Roberts G, Hall NJ, Friedmann PS, Singh H, Bennett CL, Ardern-Jones MR, Polak ME. Sirvent S, et al. Among authors: ardern jones mr. Nat Commun. 2023 May 19;14(1):2880. doi: 10.1038/s41467-023-38588-1. Nat Commun. 2023. PMID: 37208336 Free PMC article.
Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical trial.
Flohr C, Cork MJ, Ardern-Jones MR, Eichenfield LF, Barbarot S, Feeney C, Rojo R, Lazariciu I, Nesnas J. Flohr C, et al. Among authors: ardern jones mr. J Dermatolog Treat. 2023 Dec;34(1):2200866. doi: 10.1080/09546634.2023.2200866. J Dermatolog Treat. 2023. PMID: 37036183 Free article. Clinical Trial.
Successful dose reduction of dupilumab in atopic dermatitis.
Ardern-Jones MR, Buchanan EE, Njungu S, O'Driscoll D. Ardern-Jones MR, et al. Br J Dermatol. 2023 Apr 20;188(5):678-679. doi: 10.1093/bjd/ljad011. Br J Dermatol. 2023. PMID: 36662536 No abstract available.
97 results